title: Clonal reduction of CTL-P and acquired allograft tolerance in various human transplantation models.
authors.affiliation: Division of Clinical Immunobiology, Department of Internal Medicine and Surgery, Innsbruck, Austria.
authors.forename: E
authors.initials: E
authors.lastname: Irschick
authors.forename: F
authors.initials: F
authors.lastname: Hladik
authors.forename: M
authors.initials: M
authors.lastname: Berger
authors.forename: D
authors.initials: D
authors.lastname: Niederwieser
authors.forename: W
authors.initials: W
authors.lastname: Herzog
authors.forename: B
authors.initials: B
authors.lastname: Zanker
authors.forename: D
authors.initials: D
authors.lastname: Kabelitz
authors.forename: K
authors.initials: K
authors.lastname: Margreiter
authors.forename: J
authors.initials: J
authors.lastname: Auböck
authors.forename: K
authors.initials: K
authors.lastname: Miller
mesh_terms: D016026:Bone Marrow Transplantation / Q000276:immunology; D016039:Corneal Transplantation / Q000276:immunology; D003524:Cyclosporins / Q000627:therapeutic use; D004817:Epidermis / Q000637:transplantation; D006801:Humans; D007108:Immune Tolerance; D016030:Kidney Transplantation / Q000276:immunology*; D016038:Skin Transplantation / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014184:Transplantation, Homologous / Q000276:immunology*
chemical_list: D003524:Cyclosporins